copyright continues to be examined as monotherapy and together with metformin, metformin and sulfonylureas, metformin and/or thiazolidinedione, and basal insulin in sufferers with sort 2 diabetes mellitus. A significant hypersensitivity response to semaglutide or to any in the excipients in copyright. Severe hypersensitivity reactions such as an